Circulating MKRN3 Levels Decline During Puberty in Healthy Boys.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 27057785.
- Also identified by DOI 10.1210/jc.2016-1488.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Initiation and progression of puberty requires concerted action of hypothalamic activating and inhibiting factors. Recently, cases of familial central precocious puberty have been linked to loss-of-function mutations of makorin RING-finger protein 3 (MKRN3) indicating a pivotal inhibitory role of the protein on GnRH secretion. To investigate peripubertal circulating MKRN3 levels in healthy boys. Population-based longitudinal study in healthy Danish boys. General community. Healthy boys (n = 60) aged (median [range]) 9.3 (5.8-11.8) years at baseline followed for 6.0 (0.5-7.6) years (2006-2014) with blood sampling every 6 months. None. Serum levels of MKRN3: 623 samples, median (range) 12 (2-14) per boy. MKRN3 levels declined before onset of puberty; the geometric mean (95% confidence interval) 5 years before onset of puberty vs last visit before onset of puberty was 216 (169-272) pg/mL vs 128 (118-139) pg/mL (P < .001), respectively. MKRN3 levels continued to decrease as puberty progressed. MKRN3 levels were not associated with age at onset of puberty. Declining MKRN3 before pubertal onset support MKRN3 as an inhibitor of GnRH secretion during midchildhood.
Medical subject headings
- Puberty
- Ribonucleoproteins